Pengxun Han Selected Research

Ethanolamine (Colamine)

3/2022	Combined treatment with niclosamide ethanolamine and artemether combination improves type 1 diabetes via the targeting of liver mitochondria.
1/2021	Niclosamide ethanolamine ameliorates diabetes-related muscle wasting by inhibiting autophagy.
1/2020	Niclosamide ethanolamine attenuates systemic lupus erythematosus and lupus nephritis in MRL/lpr mice.
1/2019	Niclosamide ethanolamine protects kidney in adriamycin nephropathy by regulating mitochondrial redox balance.
1/2018	Niclosamide ethanolamine improves diabetes and diabetic kidney disease in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pengxun Han Research Topics

Disease

10	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 01/2017
6	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2022 - 01/2016
5	Hypertrophy 01/2022 - 01/2018
3	Wounds and Injuries (Trauma) 01/2022 - 01/2013
3	Kidney Diseases (Kidney Disease) 01/2022 - 01/2019
3	Body Weight (Weight, Body) 01/2020 - 01/2013
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2018
2	Muscular Atrophy (Muscle Atrophy) 01/2021 - 01/2018
2	Hyperglycemia 01/2019 - 01/2019
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2019 - 01/2019
1	Starvation 01/2021
1	Lupus Nephritis 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Atrophy 01/2020
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020
1	Inflammation (Inflammations) 01/2020
1	Malaria 01/2019
1	Hereditary Nephritis (Alport Syndrome) 01/2019
1	Albuminuria 07/2018
1	Neoplasms (Cancer) 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Fibroadenoma 01/2018

Drug/Important Bio-Agent (IBA)

6	Artemether FDA Link 03/2022 - 01/2019
6	AlbuminsIBA 01/2020 - 01/2018
5	Ethanolamine (Colamine)IBA 03/2022 - 01/2018
5	Niclosamide FDA Link 03/2022 - 01/2018
4	SaltsIBA 01/2021 - 01/2018
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2013
4	astragaloside AIBA 01/2020 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
3	Streptozocin (Streptozotocin)FDA Link 01/2021 - 01/2018
2	Blood Glucose (Blood Sugar)IBA 03/2022 - 07/2018
2	Insulin (Novolin)FDA Link 01/2021 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 01/2019
2	renalaseIBA 01/2018 - 01/2013
1	AntioxidantsIBA 01/2022
1	Enalapril FDA LinkGeneric 01/2022
1	Amino Acids FDA Link 01/2022
1	Autophagy-Related ProteinsIBA 01/2021
1	Biological ProductsIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	LipidsIBA 01/2020
1	Serum AlbuminIBA 01/2019
1	artemisinin (artemisinine)IBA 01/2019
1	CollagenIBA 01/2019
1	Ether (Diethyl Ether)IBA 01/2019
1	Glucagon (Glukagon)FDA Link 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2019
1	Monocarboxylic Acid TransportersIBA 01/2019
1	Acetylglucosaminidase (NAGase)IBA 07/2018
1	Transforming Growth Factor beta (TGF-beta)IBA 07/2018
1	CreatinineIBA 07/2018
1	Lipocalin-2IBA 07/2018
1	UbiquitinIBA 01/2018
1	Caspase 3 (Caspase-3)IBA 01/2018
1	ResveratrolIBA 01/2018
1	Mitogen-Activated Protein Kinase 3IBA 01/2018
1	Estrogen ReceptorsIBA 01/2018
1	Huang QiIBA 01/2016

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2020
1	Intraperitoneal Injections 01/2021
1	Lasers (Laser) 01/2018